Dan Brahmy, CEO of Cyabra, appeared on The Big Biz Show to discuss the rising threat of online disinformation driven by fake accounts, bots, and AI-generated content. He highlighted Cyabra's AI-powered platform that detects coordinated inauthentic activity and manipulated narratives, helping governments and enterprises protect digital trust. The interview emphasized the growing need for advanced tools to safeguard public discourse and national security. It is available on multiple TV, radio, and podcast platforms.
Dan Brahmy, CEO of Cyabra, is featured on The Big Biz Show discussing online disinformation. For readers following the Technology sector, here is Pluang's market snapshot as of Oct 29, 2026 19:13 WIB: out of 150 priced US tech stocks, 21 rose and 127 fell. Notable movers include CRWD at USD 247.95 with a 1-day change of -7.02% and a typical hold time of 98 days, PANW at USD 367.02 down 6.96% with 91% buy order activity, and TEAM at USD 205.75 down 6.53% with 100% buy order activity.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
